Aims/hypothesis Human adipose tissue macrophages (ATMs) display an alternatively activated (M2) phenotype, but are still able to produce excessive inflammatory mediators. However, the processes driving this particular ATM phenotype are not understood. Genome-wide association studies associated the CDKN2A locus, encoding the tumour suppressor p16 INK4A , with the development of type 2 diabetes. In the present study, p16
MDMs mediated by siRNA increased the expression of M2 marker genes and enhanced the response to lipopolysaccharide (LPS), to give a phenotype resembling that of ATM. By contrast, adenovirus-mediated overproduction of p16 INK4A in MDMs diminished M2 marker gene expression and the response to LPS. Western blot analysis revealed that p16
INK4A overproduction inhibits LPS-and palmitateinduced Toll-like receptor 4 (TLR4)-nuclear factor of κ light polypeptide gene enhancer in B cells (NF-κB) signalling. 
Conclusions/interpretation

Introduction
Macrophage infiltration into adipose tissue (AT) reflects the low-grade inflammatory state characterising obesity and insulin resistance [1] . Obesity-induced adipocyte hypertrophy causes adipocyte inflammation and cell death triggering macrophage accumulation. These AT macrophages (ATMs) accumulate in AT, surrounding dead adipocytes and forming so-called crown-like structures (CLS) [2] . Macrophages exhibit different activation states allowing them to exert specialised functions: classically activated (M1) macrophages produce high levels of inflammatory mediators such as TNF, IL-6 and cyclo-oxygenase 2 (COX2), while alternatively activated (M2) macrophages produce anti-inflammatory cytokines [3] . In vitro, monocyte differentiation into M2 macrophages is induced by stimulation with T helper 2 (Th2) cytokines, such as IL-4 or IL-13, or into M1 macrophages by stimulation with IFNγ or lipopolysaccharide (LPS) [4] . M2 markers include mannose receptor, C type 1 (CD206), the haptoglobinhaemoglobin scavenger receptor (CD163) and the chemokine chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) (CCL18 [also known as AMAC1]) [4] . In obesity, inflammatory cytokine production by ATMs increases significantly. Based on animal studies it was proposed that obesity promotes the recruitment of M1 macrophages into AT and/or induces a shift of M2 resident macrophages toward the M1 state [5] . Indeed, mouse ATMs form a heterogeneous population including both M1 and M2 subsets [6] . However, in humans, ATMs have a more complex phenotype, possibly depending on their localisation within the AT [7, 8] . Notwithstanding, the molecular mechanisms determining this particular polarisation remain elusive. p16
INK4A
, encoded by the CDKN2A locus, is a cell cycle inhibitor which blocks cyclin D/cyclin-dependent kinase 4 (CDK4) kinase activity by binding to the catalytic subunit of CDK4, thereby preventing retinoblastoma protein phosphorylation and subsequent liberation of the E2F1 transcription factor. Hence, the transcription of genes required for progression to the S phase is restrained [9] . Historically, p16
INK4A has been studied in relation to cancer and many human tumours display altered p16
INK4A levels [10] . Because of its role in cell cycle exit, p16
INK4A plays a role in senescence. For instance, mammary epithelial cells, fibroblasts and T lymphocytes accumulate p16 INK4A during ageing [11] . More recently, p16
INK4A was shown to be absent in induced pluripotent stem cells, but to be reinduced during cellular reprogramming, highlighting a role of p16 INK4A in cell fate determination [12] . However, little is known about whether p16 INK4A exerts functions unrelated to cell cycle control. Interestingly, a region near the CDKN2A locus has been associated with type 2 diabetes development [13] . As macrophage infiltration and inflammation are key events of type 2 diabetes and obesity, the present study aimed to investigate the connection between p16
INK4A levels in human ATMs and their particular phenotype.
Methods
Human ATM purification Human ATMs were purified from visceral AT biopsies as described by Mayi et al. [14] from non-diabetic morbidly obese patients (BMI 55.7±3 kg/m²) undergoing bariatric surgery with informed consent. The study was approved by the ethics committee of the Centre Hospitalier Régional Universitaire de Lille, France, under the ABOS (Atlas Biologique de l'Obésité Sévère) and OMENTOB (OMENTectomie au cours de la gastrectomie en manchon chez l'OBèse sévère: étude pilote contrôlée et randomisée) frameworks. None of the patients had clinical symptoms of systemic inflammation or malignancies.
Immunohistochemical analysis and laser-capture microdissection of human atherosclerotic plaques Human atherosclerotic plaques were removed from patients eligible for surgical carotid endarterectomy recruited at the Cardiovascular Surgery Department, Hospital of Lille, France. Informed consent was obtained from all patients. For immunohistochemical analysis and macrophage detection, endogenous peroxidase activity was quenched and serial 8 μm cryosections were stained with monoclonal antihuman CD68 antibodies (Dako Corporation, Zone d'Activités du Buisson de la Couldre, France) followed by detection with biotinylated secondary antibodies and streptavidinhorseradish peroxidase. Immunostaining was visualised using the 3-amino-9-ethylcarbazole (AEC) substratechromogen system.
Adjacent cryosections of atherosclerotic plaques containing CD68
+ macrophage-rich areas were dehydrated in a series of graded alcohols, cleared in xylene and prepared for laser-capture microdissection, performed on an ArcturusXT Microdissection Instrument with CapSure Macro LCM Caps (MDS Analytical Technologies, Saint Gregoire, France). Macrophage-rich areas were captured from four adjacent 8 μm sections and pooled for RNA extraction. RNA extraction from isolated samples was performed using the Picopure RNA extraction kit (MDS Analytical Technologies). RNA quality was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Massy, France) and amplified in two rounds using the ExpressArt TRinucleotide mRNA amplification Nano kit (AmpTec, Vicq, France).
Human monocyte differentiation into macrophages
Mononuclear cells isolated from blood of healthy donors (Ficoll gradient) were cultured in RPMI 1640 medium with 10% (vol./vol.) pooled human serum for 7-12 days. During this time, monocytes were differentiated into mature monocyte-derived macrophages (MDMs) or into M2 macrophages by supplementing the medium with IL-4 (15 ng/ml) starting from day 0. Macrophages were treated with either LPS (100 ng/ml) for 1 or 2 h or with palmitate (500 μmol/l) for 1 h. Table 1 ). RNA levels were normalised to cyclophilin A mRNA.
Proteins were determined by western blot analysis using a monoclonal antibody against human p16
INK4A (Beckton Dickinson), signal transducer and activator of transcription 6, interleukin-4 induced (STAT6) and phosphorylated STAT6 (9362 and 9361), phospho-IKKα,β (2681), IκBα (9242), phospho-P38 (9211) (Cell Signaling), Toll-like receptor 4 (TLR4) (sc-10741), and β-actin (sc-1616) (Santa Cruz). Levels of TNF protein in culture media were measured using an ELISA (R&D Systems, Lille, France).
Statistical analysis Data are from representative experiments. Each set of experiments was repeated at least three times with similar results. Statistical significance was determined by the Student's t test. Values are reported as means±SD. Values of p<0.05 were considered significant and different levels of significance are represented by asterisks: *p<0.05, **p<0.01 and ***p<0.001.
Results
Human p16
INK4A expression is lower in ATMs than in MDMs or AMs Expression of p16 INK4A in human ATMs was compared with MDMs differentiated from monocytes from the same obese donors. Confirming previous reports on the human ATM phenotype [8] , mRNA expression of typical M2 markers (AMAC1 [also known as CCL18] and IL10) and of the inflammatory cytokine TNF was higher in ATMs compared with MDMs (data not shown). ATMs expressed significantly lower p16
INK4A mRNA levels than MDMs as well as CD68-positive atherosclerotic plaque macrophages (AMs) (Fig. 1a) . This observation suggests that p16 INK4A expression is specifically decreased in ATMs. Interestingly, in vitro macrophage differentiation led to the induction of p16 INK4A protein levels (Fig. 1b) , whereas this induction was inhibited in macrophages differentiated in the presence of IL-4, leading to M2 polarisation (Fig. 1c) . All observed changes in p16
INK4A levels occurred without alterations in cell cycle progression (data not shown).
As peroxisome proliferator-activated receptor (PPAR)α activation induces p16 INK4A expression in smooth muscle cells [15] and as PPARγ activation enhances M2 polarisation [16] , we investigated whether PPARγ activation with GW929 affects p16 INK4A expression. GW929 treatment of mature MDM macrophages resulted in a very mild inhibition of p16 INK4A expression while GW929 treatment had no effect on p16 INK4A levels in mature M2 macrophages (ESM Fig. 1a) . Thus, p16
INK4A is not induced by PPARγ activation in human macrophages. Moreover, enhancing M2 polarisation by adding GW929 to monocytes at the start of differentiation [16] did not further decrease p16
INK4A expression (ESM Fig. 1b) , suggesting that downregulation of p16
INK4A is mainly IL-4 dependent. These data show that p16 INK4A expression is low in human ATMs and that in vitro differentiation of primary monocytes into M2 macrophages mimics this effect.
Silencing of p16
INK4A in MDMs induces a phenotype resembling human ATMs As ATMs display low p16
INK4A
expression compared with MDMs and as M2 polarisation lowers p16
INK4A levels, we determined whether a direct link exists between p16 INK4A levels and macrophage polarisation. Silencing p16 INK4A in MDMs by approximately 60% using siRNA (Fig. 2a) increased mRNA expression of the M2 markers CD206 (also known as MRC1) and AMAC1, while the expression of CD163, an M2 marker typically downregulated when macrophages are differentiated in vitro with IL-4 [4] , decreased (Fig. 2c) .
Activation of MDMs with LPS increased p16
protein levels (Fig. 2b) knockdown induced an M2-phenotype (Fig. 2c) , the expression of the inflammatory response genes TNF, COX2 and IL6 was more strongly induced by LPS (Fig. 2d) . Furthermore, LPS-induced TNF secretion was higher in cells transfected with p16 INK4A siRNA (Fig. 2e ). The production of high levels of inflammatory cytokines upon activation, despite being M2 polarised, resembles the human ATM phenotype [8] . INK4A levels are low in ATMs and M2 macrophages. a Human ATMs were purified from visceral AT biopsies; monocytes purified from whole blood of the same obese donors (n=9) were differentiated for 7 days into MDMs. CD68 + AMs were isolated from human carotid plaques (n=6) by laser-capture microdissection. mRNA was isolated and quantitative RT-PCR was performed to measure mRNA expression levels of p16 INK4A in the cell types. Statistically significant differences are indicated (t test; *p<0.05, **p<0.01 compared with ATM). b p16 INK4A protein was detected by western blot at different time points during macrophage differentiation from blood monocytes of healthy donors. c p16 INK4A protein was detected by western blot at different time points during alternative macrophage differentiation of blood monocytes from healthy donors in the presence of Importantly, p16
INK4A overproduction by adenovirusmediated gene transfer (Fig. 3a) showed an expression pattern opposite to the one observed with p16 INK4A silencing, i.e. downregulation of CD206 and AMAC1, upregulation of CD163 (Fig. 3b) and a decreased response to LPS (Fig. 3c) .
Together, these data indicate that downregulation of p16
INK4A levels results in an M2-like phenotype associated with an exacerbated response to inflammation, reflecting the phenotype of ATMs, while p16
INK4A overproduction inhibits the ATM phenotype.
p16
INK4A interferes with the TLR4 response upstream of NFκB without affecting TLR4 levels A major pathway involved in regulating M2 genes involves STAT6 signalling [3] . However, modulation of p16 INK4A levels did not affect phosphorylation of STAT6 under basal conditions or after IL-4 treatment (data not shown). LPS signalling involves TLR4-mediated phosphorylation of p38 and of inhibitor of nuclear factor κB kinase (IKK) α,β [17] . The latter phosphorylates nuclear factor of κ light polypeptide gene enhancer in B-cells inhibitor, alpha (IκBα), leading to IκBα degradation and subsequent release and nuclear translocation of nuclear factor of κ light polypeptide gene enhancer in B cells (NFκB), thereby initiating the transcriptional activation of inflammatory genes [17] . Subsequent to its activation, TLR4 protein is degraded [18] . Although p16
INK4A overproduction decreased the response to LPS (Fig. 3c) , this effect was unrelated to TLR4 protein levels in basal or in LPS-stimulated conditions, the latter resulting in the complete degradation of TLR4 (Fig. 4) , pointing to an effect downstream in this pathway. Indeed, LPS-induced phosphorylation of p38 and of IKKα,β was less pronounced in cells overproducing p16 INK4A (Fig. 4) . In line, IκBα, which inhibits the nuclear translocation of NFκB [17] , was less degraded on LPS treatment (Fig. 4) . Notably, under unstimulated conditions, p16
INK4A overexpression induced lower levels of anti-inflammatory IκBα (Fig. 4) . Obesity is associated with increased levels of NEFAs, such as palmitate [19] , which are known to act as TLR4 ligands [20] . In line with the observations on LPS treatment, MDM overproducing p16
INK4A displayed decreased phosphorylation of p38 and IKKα,β after stimulation with palmitate (ESM Fig. 2) . These results suggest that p16
INK4A directly interferes with TLR4-NFκB signalling, resulting in an altered inflammatory profile.
Discussion
We show that ATMs from obese patients as well as IL4-polarised human M2 macrophages in vitro are characterised by low p16
INK4A expression compared with, respectively, MDMs or AMs and to LPS-induced M1 macrophages in vitro. Moreover, siRNA-mediated down-modulation of p16 INK4A in MDMs induced an M2 phenotype while increasing the inflammatory response to LPS, thus inducing an ATM-like phenotype. Overproduction of p16 
